FusionAi closes 50M yuan Pre-A round to boost deployment of medical AI products

Recently, FusionAi announced the official completion of a RMB 50 million Pre-A funding round. This round was led by Marathon Venture Partners, with existing shareholder Long Hill Capital making an oversubscribed follow-on investment. Lighthouse Capital served as the exclusive financial advisor.

The raised capital will be primarily used for technological iteration of the FusionAi series of medical AI products, their nationwide scaled deployment and channel development in China, and further expansion of the talent team. This will continuously strengthen the company's leading position in the medical artificial intelligence field.

Currently, driven by policy support, technological innovation, and an accelerating aging population, China's Healthcare Information Technology (HIT) market has entered a phase valued at hundreds of billions of RMB. The rise of generative artificial intelligence presents unprecedented opportunities for innovation within the healthcare informatization sector.

Compared to traditional healthcare IT, generative AI—leveraging its capabilities in natural language understanding, generation, and intelligent reasoning—offers a novel pathway to address systemic challenges such as high physician workload, significant hospital operational and revenue pressures, and the high costs associated with system customization.

Based on a profound understanding of this trend, FusionAi was among the first to propose the vision of "AI-Driven Hospital-Wide Processes," aiming to advance generative AI from an auxiliary tool to a force for the systematic reshaping of clinical and operational hospital systems.

FusionAi has concretized this strategy into what it terms the hospital's "FSD Moment" — drawing an analogy to Full Self-Driving technology — aiming to redefine entire hospital workflows, from data governance and patient management to patient services and clinical diagnosis and treatment, through AI capabilities.

By deeply integrating generative AI into every facet of hospital operations, FusionAi achieves systematic coordination across automated data governance, proactive identification of at-risk patients, precision patient services, and efficient clinical service delivery with quality control. This approach fundamentally transcends the functional limitations of traditional information systems, propelling hospitals into a new operational era driven by artificial intelligence.

Serving as the core foundation for Medical FSD, FusionAi provides leading FusionAi medical models and intelligent agents, establishing a comprehensive medical intelligence service system that covers the entire patient journey from pre-consultation, through diagnosis and treatment, to post-consultation follow-up. This drives hospitals' profound transition from informatization to intelligentization.

Leveraging its robust product capabilities, FusionAi has established a nationwide business presence in China, having served over 200 hospital groups, large-to-medium medical institutions, and health administration agencies. Its client portfolio includes renowned top-tier Chinese hospitals such as Zhongnan Hospital of Wuhan University, Hangzhou First People's Hospital, Affiliated Hospital of Jining Medical University, and Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. The company comprehensively supports these institutions in achieving the leapfrog development from "informatization" to "AI-powered intelligentization."

Wu Di, Founder and CEO of FusionAi, stated: "Generative AI represents the most disruptive general-purpose technological revolution since the internet and mobile internet, with its social value being particularly prominent in the healthcare field, which is centered on interaction and decision-making. We position AI as a collaborative partner for physicians, not a replacement, empowering it with the capabilities to listen, comprehend, generate, and assist in decision-making, thereby advancing the diagnostic and treatment process towards greater efficiency, safety, and precision.

"In the future, hospital informatization will transform from a simple collection of traditional business systems into an autonomous intelligent system driven by AI agents at its core. Leveraging AI technology, FusionAi is building a comprehensive AI management system that covers the entire patient pathway—from pre-consultation guidance and in-consultation assistance to post-consultation quality control and data governance. This establishes an AI-driven hospital management model, assisting hospitals in achieving intelligent transformation, enhancing physicians' professional capabilities, and ensuring equitable patient access to high-quality medical services."